|
C1ORF58 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.04529999999959E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.603500E-04 |
| Normal-vs-Stage2 |
9.826300E-04 |
| Normal-vs-Stage3 |
1.62550999999178E-05 |
| Normal-vs-Stage4 |
8.580300E-03 |
| Stage1-vs-Stage2 |
7.570200E-01 |
| Stage1-vs-Stage3 |
3.487400E-01 |
| Stage1-vs-Stage4 |
7.731000E-01 |
| Stage2-vs-Stage3 |
7.180800E-01 |
| Stage2-vs-Stage4 |
6.538600E-01 |
| Stage3-vs-Stage4 |
3.622000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.040300E-04 |
| Normal-vs-AfricanAmerican |
2.512600E-01 |
| Normal-vs-Asian |
2.786200E-04 |
| Caucasian-vs-AfricanAmerican |
1.299610E-01 |
| Caucasian-vs-Asian |
6.202800E-01 |
| AfricanAmerican-vs-Asian |
8.530300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63048999999305E-05 |
| Normal-vs-Female |
1.770420E-04 |
| Male-vs-Female |
2.063000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239120E-03 |
| Normal-vs-Age(41-60Yrs) |
3.42389999996584E-06 |
| Normal-vs-Age(61-80Yrs) |
1.124890E-03 |
| Normal-vs-Age(81-100Yrs) |
1.001970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.963400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.190600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.588200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.023800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.787800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.342400E-02 |
| Classical-VS-Follicular |
7.790500E-04 |
| Classical-VS-Other |
9.932200E-02 |
| Classical-VS-Normal |
2.777600E-03 |
| Tall-VS-Follicular |
6.476000E-01 |
| Tall-VS-Other |
2.879000E-01 |
| Tall-VS-Normal |
1.585210E-04 |
| Follicular-VS-Other |
4.307000E-01 |
| Follicular-VS-Normal |
8.71840000193913E-08 |
| Other-VS-Normal |
2.224100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7390000000006E-06 |
| Normal-vs-N1 |
2.182100E-04 |
| N0-vs-N1 |
8.741400E-01 |
|
|
